Home/Filings/4/0000929638-25-003710
4//SEC Filing

Sweiti Hussein 4

Accession 0000929638-25-003710

CIK 0001980845other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:54 PM ET

Size

5.4 KB

Accession

0000929638-25-003710

Insider Transaction Report

Form 4
Period: 2025-09-30
Sweiti Hussein
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-09-30+600,000600,000 total
    Exercise: $6.83Exp: 2035-09-30Common Shares (600,000 underlying)
Footnotes (1)
  • [F1]Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on September 29, 2026, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the remaining three years, subject to the reporting person's continued service.

Documents

1 file

Issuer

enGene Holdings Inc.

CIK 0001980845

Entity typeother

Related Parties

1
  • filerCIK 0002088436

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:54 PM ET
Size
5.4 KB